361 related articles for article (PubMed ID: 30451123)
1. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease.
Pashazadeh P; Marjani A; Asadi J; Khoshnia M
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):541-547. PubMed ID: 30451123
[TBL] [Abstract][Full Text] [Related]
2. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
3. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
[TBL] [Abstract][Full Text] [Related]
4. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacogenomics of thiopurine S-methyltransferase.
Zhou S
Curr Clin Pharmacol; 2006 Jan; 1(1):119-28. PubMed ID: 18666383
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.
Carvalho AT; Esberard BC; Fróes RS; Rapozo DC; Grinman AB; Simão TA; Santos JC; Carneiro AJ; Ribeiro-Pinto LF; de Souza HS
World J Gastroenterol; 2014 Mar; 20(12):3327-34. PubMed ID: 24696613
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
Zhu Q; Cao Q
Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
[TBL] [Abstract][Full Text] [Related]
9. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
10. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
[TBL] [Abstract][Full Text] [Related]
11. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
[TBL] [Abstract][Full Text] [Related]
12. [Frequency of serious adverse events of thiopurine treatment in normal thiopurine S-methyltransferase genotype children with inflammatory bowel disease].
Tárnok A
Orv Hetil; 2019 Feb; 160(5):179-185. PubMed ID: 30686035
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
Takatsu N; Matsui T; Murakami Y; Ishihara H; Hisabe T; Nagahama T; Maki S; Beppu T; Takaki Y; Hirai F; Yao K
J Gastroenterol Hepatol; 2009 Jul; 24(7):1258-64. PubMed ID: 19682195
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece.
Coucoutsi C; Emmanouil G; Goulielmos G; Sfakianaki O; Koutroubakis IE; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1284-1289. PubMed ID: 28857898
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.
Cuffari C; Dassopoulos T; Turnbough L; Thompson RE; Bayless TM
Clin Gastroenterol Hepatol; 2004 May; 2(5):410-7. PubMed ID: 15118980
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
Dervieux T; Meyer G; Barham R; Matsutani M; Barry M; Boulieu R; Neri B; Seidman E
Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients.
Desatova B; Hlavaty T; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Kadasi L; Huorka M; Batovsky M
Bratisl Lek Listy; 2013; 114(6):330-2. PubMed ID: 23731044
[TBL] [Abstract][Full Text] [Related]
18. AN EPIDEMIOLOGICAL STUDY OF THIOPURINE-METHYLTRANSFERASE VARIANTS IN A CROATIAN INFLAMMATORY BOWEL DISEASE PATIENT COHORT.
Ladić A; Božina N; Borzan V; Brinar M; Vucelić B; Cuković-Cavka S
Acta Clin Croat; 2016 Mar; 55(1):16-22. PubMed ID: 27333713
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients.
Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Syriopoulou VP; Goutas N; Vlachodimitropoulos D; Anagnou NP; Roma-Giannikou E
J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817
[TBL] [Abstract][Full Text] [Related]
20. Successful azathioprine treatment with metabolite monitoring in a pediatric inflammatory bowel disease patient homozygous for TPMT*3C.
Lee MN; Woo HI; Lee YM; Kang B; Kim JW; Choe YH; Lee SY
Yonsei Med J; 2013 Nov; 54(6):1545-9. PubMed ID: 24142665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
